risk stratification
Genetic Technologies, WashU Team up to Study Breast Cancer Risk in Woman of African Descent
The Australian company is working with the Institute for Public Health in St. Louis to expand the predictive capability of its GeneType breast cancer risk test.
Polygenic Risk Scores for Breast, Prostate Cancer Adaptable for Cross-Ancestry Use, Study Shows
The researchers said the approach could be a short-term measure while genetic studies of more diverse ancestral populations are performed.
Through its real-world evidence registry, the firm hopes to further validate its NSCLC recurrence risk test as a tool for guiding adjuvant treatment.
The company is providing its 400-gene test through a physician-involved DTC model akin to Color and Invitae, but with content across a much larger swath of disease and health.
Volpara Adding Invitae Genetic Test Ordering to Breast Risk Software Platform
The companies have inked an agreement under which Volpara can integrate Invitae's test services into its suite of risk assessment products.